Arvinas (ARVN) Return on Sales (2017 - 2026)

Arvinas (ARVN) recorded quarterly Return on Sales of 0.04% in Q1 2026, up 47.96% quarter-over-quarter from 0.07% in Q4 2025, and down 4.0% on a YoY basis from 0.04% in Q1 2025.

Arvinas (ARVN) Return on Sales (2017 - 2026) Analysis & Trends

Arvinas' Return on Sales history runs 10 years deep, the most recent figure standing at 0.04% for Q1 2026.

  • In Q1 2026, Return on Sales fell 4.0% year-over-year to 0.04%; the TTM figure through Mar 2026 stood at 0.02% (down 2.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
  • Return on Sales was 0.04% for Q1 2026 at Arvinas, up from 0.07% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.04% in Q4 2023 to a low of 0.07% in Q4 2025.
  • Historically, Return on Sales has averaged 0.02% across 5 years, with a median of 0.02% in 2022.
  • The sharpest annual moves came in 2022 and 2025: Return on Sales increased 7 bps in 2022, then declined 6 bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.02% in 2022, then jumped by 269 bps to 0.04% in 2023, then plunged by 121 bps to 0.01% in 2024, then slumped by 831 bps to 0.07% in 2025, then surged by 48 bps to 0.04% in 2026.
  • The last three Return on Sales figures came in at 0.04% (Q1 2026), 0.07% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.00%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 0.00%
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.00%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Arvinas 492.16 Mn -122.74 Mn - -0.04%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.04%
Dec 31, 2025 -0.07%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.03%
Mar 31, 2025 0.00%
Dec 31, 2024 -0.01%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 -0.03%
Dec 31, 2023 0.04%
Sep 30, 2023 -0.02%
Jun 30, 2023 -0.01%
Mar 31, 2023 -0.02%
Dec 31, 2022 -0.02%
Sep 30, 2022 -0.02%
Jun 30, 2022 -0.02%
Mar 31, 2022 -0.02%
Dec 31, 2021 -0.01%
Sep 30, 2021 -0.05%
Jun 30, 2021 -0.09%